Morning Venge,
These guys won't support a CR, they still believe BMCG backup up US$9.3mil in convertible equity was available,
You only need to look at the December QTR cash flow report and compare it to the March QTR.
And compare it to the March QTR report.
The pump crew also failed to detail Gemcorps US$5mil in backup funding is an " Incremental debt"
You are spot on with your assessment, WKT has previously run the accounts dry twice, which has caused the company to raise funds with significant discounts. the last CR had a 43% discount. We heard yesterday there are more delays with the first concentrate being available. there are no details on Gemcorps loan servicing requirements (2 QTR'S of loan repayments that are required at all times) If this is only the interest payable for the loan, WKT has enough cash in the back to cover this requirement, although if they need the principal as well, they don't have enough.
I cannot see Gemcorp advancing the US$5mil incremental funds if the debt servicing requirements are not being met for the existing US$20mil fully drawn loan.
Since you are only new to WKT, these pumpers are not open to reasonable discussion, they don't believe any of the issues other companies have faced will occur with WKT, and they don't hold management accountable for the significant blowouts in construction or commissioning. For a project to have been quoted to only take 9-12 months to get into production, it has nearly been 3 years since WKT made this claim.
- Forums
- ASX - By Stock
- WKT
- Ann: Wet Commissioning Advances as Ore Feeds Through Concentrator
Ann: Wet Commissioning Advances as Ore Feeds Through Concentrator, page-104
-
- There are more pages in this discussion • 223 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
Add WKT (ASX) to my watchlist
|
|||||
Last
10.5¢ |
Change
-0.003(2.33%) |
Mkt cap ! $70.48M |
Open | High | Low | Value | Volume |
11.0¢ | 11.0¢ | 10.5¢ | $21.84K | 201.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 604881 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 224492 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 525791 | 0.105 |
10 | 537424 | 0.100 |
2 | 120000 | 0.099 |
1 | 130000 | 0.098 |
1 | 150000 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 217628 | 5 |
0.115 | 990750 | 4 |
0.120 | 626697 | 11 |
0.125 | 447166 | 9 |
0.130 | 225598 | 4 |
Last trade - 12.11pm 12/07/2024 (20 minute delay) ? |
Featured News
WKT (ASX) Chart |